Prognostic factors influencing visual outcome of photodynamic therapy for subfoveal choroidal neovascularization in pathologic myopia
- 19 August 2004
- journal article
- research article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 138 (3), 434-438
- https://doi.org/10.1016/j.ajo.2004.04.055
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopiaOphthalmology, 2003
- Long-term visual prognosis of choroidal neovascularization in high myopia: A comparison between age groupsOphthalmology, 2002
- GUIDELINES FOR USING VERTEPORFIN (VISUDYNE®) IN PHOTODYNAMIC THERAPY TO TREAT CHOROIDAL NEOVASCULARIZATION DUE TO AGE-RELATED MACULAR DEGENERATION AND OTHER CAUSESRetina, 2002
- Statistics Notes: Analysing controlled trials with baseline and follow up measurementsBMJ, 2001
- Surgical removal of subfoveal choroidal neovascularisation in highly myopic patientsBritish Journal of Ophthalmology, 2001
- Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization—verteporfin in photodynamic therapy report 2American Journal of Ophthalmology, 2001
- Visual acuity outcomes of patients 50 years of age and older with high myopia and untreated choroidal neovascularizationOphthalmology, 1999
- PATHOLOGIC FINDINGS IN PATHOLOGIC MYOPIARetina, 1992
- PHOTOCOAGULATION SCAR EXPANSION AFTER LASER THERAPY FOR CHOROIDAL NEOVASCULARIZATION IN DEGENERATIVE MYOPIARetina, 1990
- Myopic Macular DegenerationInternational Ophthalmology Clinics, 1981